ArticleBMC medicine2024

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.

Chaoji Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.